As we know, many things are beyond his control, but he sure has a long pattern of dangling that 'carrot' in front of investors, those very investors that have kept the company 'alive' all these years and which he has publicly 'put down' on a number of times over the years.
I will say again, I believe, more now than ever going forward, he's not the right ceo for this biotech and not one that commands much respect, imo, in professional pharma circles; that's clearly Dr. Lanza.
News 
Market Data 
Discover 
AI
